C-1027. Antineoplastic antibiotic

Drugs of the Future

Volumn 24, Issue 8, 1999, Pages 847-852

  Wang, Xing Wang ^a   Xie, Hong ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC C 1027; AZASERINE; BLEOMYCIN; CHROMOMYCIN; DACTINOMYCIN; DAUNORUBICIN; DOXORUBICIN; MITOMYCIN C; RUFOCROMOMYCIN; SIBIROMYCIN; ZINOSTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD TOXICITY; CANCER CELL CULTURE; CANCER INHIBITION; DRUG CONFORMATION; DRUG EFFECT; DRUG ISOLATION; DRUG POTENCY; DRUG SAFETY; DRUG SYNTHESIS; HUMAN; MOLECULAR WEIGHT; MOUSE; NONHUMAN; STREPTOMYCES; STRUCTURE ACTIVITY RELATION;

EID: 0032843973     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1999.024.08.545524     Document Type: Article

References (24)

1. Zhen, Y.S., Xue, Y.C. Use of marine spermatogonial assay as prescreen for antitumor drugs. In: Proceedings of the 13th International Congress on Chemotherapy. K.H. Spitzy, K. Karrer (Eds.). Egermann: Vienna 1983, Part 223, No. 7: 38-44.
2. Hu, J., Xue, Y.C., Xie, M.Y., Zhang, R., Otani, T., Minami, Y., Yamada, Y., Marunaka, T. A new macromolecular antitumor antibiotic, C-1027. I. Discovery, taxonomy of producing organism, fermentation and biological activity. J Antibiotics 1988, 41: 1575-9.
3. Otani, T., Minami, Y., Marunaka, T., Zhang, R., Xie, M.Y. A new macromolecular antitumor antibiotic, C-1027. II. Isolation and physico-chemical properties. J Antibiotics 1988, 41: 1580-5.
4. Otani T., Minami, Y., Sakawa, K., Yoshida, K. Isolation and characterization of non-protein chromophore and its degradation product from antibiotic C-1027. J Antibiotics 1991, 44: 564-8.
5. Yoshida, K., Minami, Y., Azuma, R., Saeki, M., Otani, T. Structure and cycloaromatization of novel enediyne, C-1027 chromophore. Tetrahedron Lett 1993, 34: 2637-40.
6. Otani, T., Yasuhara, T., Minami, Y., Shimazu, T., Zhang, R., Xie, M.Y. Purification and primary structure of C-1027-AG, a selective antagonist of antitumor antibiotic C-1027, from Streptomyces globisporus. Agric Biol Chem 1991, 55: 407-17.
7. Otani, T., Minami, Y., Marunaka, T., Zhang, R., Xie, M.Y. C-1027-AG, a selective antagonist of the macromolecular antitumor antibiotic, C-1027. J Antibiotics 1988, 41: 1696-8.
8. Kudo, K., Kikuchi, M., Ishida, N. Biogenesis of an antitumor antibiotic protein, neocarzinostatin. Antimicrob Agents Chemother 1972, 1: 289-95.
9. Zhen, Y.S., Ming, X.Y., Yu, B., Otani, T., Saito, H., Yamada, Y. A new macromolecular antitumor antibiotic, C-1027. III. Antitumor activity. J Antibiotics 1989, 42: 1294-8.
10. Zhen, Y.S., Xue, Y.C., Shao, R.G. Antitumor activity of the new enediyne antibiotic C-1027. Chin J Antibiotics 1994, 19: 164-8.
11. Sugimoto, Y., Otani, T., Oie, S., Wierzba, K., Yamada, Y. Mechanism of action of a new macromolecular antitumor antibiotic, C-1027. J Antibiotics 1990, 43: 417-21.
12. Xu, Y.J., Li, D.D., Zhen, Y.S. Molecular mechanisms of action of C-1027. Sci Sin 1992, 8: 814-9.
13. Xu, Y.J., Li, D.D., Zhen, Y.S. Mode of action of C-1027, a new macromolecular antitumor antibiotic with highly potent cytotoxicity, on human hepatoma BEL-7402 cells. Cancer Chemother Pharmacol 1990, 27: 41-6.
14. Painter, R.B. Rapid test to detect agents that damage human DNA. Nature 1977, 265: 650-3.
15. Xu, Y.J. Zhen, Y.S., Goldberg, I.H. C-1027 chromophore, a potent new enediyne antitumor antibiotic, induces sequence-specific double-strand DNA cleavage. Biochemistry 1994, 33: 5947-54.
16. Yamaizumi, M., Mekada, E., Uchida, T., Okada, Y. One molecule of diphtherial toxin fragment A introduced into a cell can kill the cell. Cell 1978, 15: 245-52.
17. Marx, J.L. Monoclonal antibodies in cancer. Science 1982, 216: 283-5.
18. Shao, R.G., Zhen, Y.S. Antitumor activity of new antibiotic C-1027 and its monoclonal antibody assembled conjugate. Acta Pharmaceut Sin 1992, 27: 486-91.
19. Zhen, Y.S., Peng, Z., Xu, Y.J., Shao, Y.G. Antitumor activity of the monoclonal antibody conjugate prepared from a highly potent antitumor antibiotic C-1027. Proc Am Assoc Cancer Res 1991, 32: 432.
20. Zhen, Y.S., Li, J.Z., Shao, Y.G., Jiang, M. A highly potent cytotoxic immunoconjugate composed of antitumor antibiotic C-1027 and rat monoclonal antibody 3A5. Proc Am Assoc Cancer Res 1993, 34: 474.
21. Li, J.Z., Jiang, M., Xue, Y.C., Zhen, Y.S. Anti-hepatoma activity of C-1027 and its Fab conjugate. Acta Pharmaceut Sin 1993, 28: 260-5.
22. Zhen, Y.S., Shao, R.G., Jiang, M., Li, J.Z., Wang, N.G., Dong, Z.W. Antitumor activity of the conjugates composed of C-1027, an antitumor antibiotic, and monoclonal antibody. Chin J Cancer Biother 1995, 2: 94-8.
23. Zhen, Y.S., Shao, R.G., Li, J.Z., Jiang, M. The use of C-1027, an antitumor antibiotic with extremely potent cytotoxicity, for making effective immunoconjugates. Antibody Immunoconj Radiopharm 1994, 7: 89.
24. Morgan, A.C.Jr., Pearson, J.W., Oldham, R.K. Preclinical evaluation of immunoconjugates. In: Immunoconjugates. Antibody Conjugates in Radioimaging and Therapy of Cancer. C.W. Vogel (Ed..). Oxford University Press: New York 1987, 241-58.